The Senior Director, Global Analytics & Insights, Cell Therapy leads insights and analysis for AstraZeneca’s Cell Therapy Enterprise, supporting priority assets from clinical development through commercialization across prioritized disease areas. The role provides deep insights and strategic direction for enterprise-level initiatives and key commercial decisions, and serves as the Global Analytics & Insights point of contact for the Cell Therapy Enterprise. It reports to the Global Commercial Head, Cell Therapy. The position partners with enterprise leadership, priority markets, and cross-functional teams to shape portfolio strategy, asset development plans, and long-range business planning. It builds understanding of disease areas, patients, healthcare professionals, market dynamics, competitors, and implications for AstraZeneca’s portfolio. The role develops evidence and market understanding to support clinical development, asset prioritization, indication strategy, and future commercialization. For priority assets and indications, the role integrates clinical, market, customer, competitor, access, and treatment-delivery insights to inform target product profiles, development choices, indication sequencing, portfolio prioritization, and forecasts. It develops quantitative analyses and business cases accounting for cell therapy considerations such as eligible patient identification, referral pathways, treatment-center readiness, manufacturing capacity, vein-to-vein time, access, and scalability. It also manages external market research, forecasting, and data/analytics vendor relationships and budgets, and explores advanced analytics and predictive modeling suited to cell therapy’s delivery model.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Director